EUVIMEDEUVIMED entdecken
Crossref

73493 Bimekizumab leads to sustained flare-free status in moderate to severe hidradenitis suppurativa: 3-year data from BE HEARD EXT

Steven Daveluy, Haley B. Naik, Ziad Reguiai, Sayaka Yamaguchi, Pablo Fernandez-Peñas, Bartosz Lukowski, Christina Crater, Nicola Tilt, Antonio Martorell

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB82

DOI: 10.1016/j.jaad.2026.04.337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Steven Daveluy und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Daveluy, S., Naik, H. B., Reguiai, Z., Yamaguchi, S., Fernandez-Peñas, P., Lukowski, B., Crater, C., Tilt, N., & Martorell, A. (2026). 73493 Bimekizumab leads to sustained flare-free status in moderate to severe hidradenitis suppurativa: 3-year data from BE HEARD EXT. Journal of the American Academy of Dermatology, 95(1), AB82. https://doi.org/10.1016/j.jaad.2026.04.337

Vancouver

Daveluy S, Naik HB, Reguiai Z, Yamaguchi S, Fernandez-Peñas P, Lukowski B, et al. 73493 Bimekizumab leads to sustained flare-free status in moderate to severe hidradenitis suppurativa: 3-year data from BE HEARD EXT. Journal of the American Academy of Dermatology. 2026;95(1):AB82. doi:10.1016/j.jaad.2026.04.337

BibTeX
@article{Daveluy2026,
  author = {Daveluy, Steven and Naik, Haley B. and Reguiai, Ziad and Yamaguchi, Sayaka and Fernandez-Peñas, Pablo and Lukowski, Bartosz and Crater, Christina and Tilt, Nicola and Martorell, Antonio},
  title = {73493 Bimekizumab leads to sustained flare-free status in moderate to severe hidradenitis suppurativa: 3-year data from BE HEARD EXT},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB82},
  doi = {10.1016/j.jaad.2026.04.337}
}
Kostenlos starten →